NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Tonix Pharma Reports First Quarter 2017 Financial Results And Provides Programs Update May 14, 2017 Amazon Has Top Secret 1492 Unit Working on Healthcare and Telemedicine July 27, 2017 Canada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds November 21, 2017
Canada's Concordia Accused of 6,000% Price Increase for Drug, Overcharging NHS by 100M Pounds November 21, 2017
